Original Source(s)
Related Content
FDA approves tau PET imaging agent
The F18-labeled agent is indicated for brain PET imaging to identify tau neurofibrillary tangle pathology.
August 14, 2026
-
2 min
FDA approves FET-PET agent for glioma
The radioactive diagnostic drug is indicated in patients aged 1 month or older and is used in conjunction with other diagnostic evaluations.
September 14, 2026
-
2 min